KREBS BIOCHEMICALS & INDUSTRIES LTD.-$
BSE: 524518
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 6.98+2.6% | 6.81-6.4% | 7.27+74.5% | 4.17-24.0% | 5.48-10.2% | 6.10-46.8% | 11.47-10.8% | 12.86 |
| Other Income | 0.16-92.2% | 2.00+49990.0% | 0.00-40.3% | 0.01-42.7% | 0.01-96.5% | 0.34+34.7% | 0.25+191.9% | 0.09 |
| Total Income | 7.14-19.0% | 8.81+21.1% | 7.28+74.4% | 4.17-24.0% | 5.49-14.7% | 6.44-45.1% | 11.72-9.5% | 12.94 |
| EXPENSES | ||||||||
| Expenditure | 9.62-13.7% | 11.15+7.2% | 10.40+0.9% | 10.32-4.6% | 10.82-26.4% | 14.69-24.5% | 19.46+4.0% | 18.70 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 0.02 | — | — |
| PROFIT | ||||||||
| PBT | -2.48-6.2% | -2.34+25.2% | -3.13+49.1% | -6.14-15.4% | -5.32+35.5% | -8.25-6.6% | -7.74-34.3% | -5.76 |
| Net Profit | -2.48-6.2% | -2.34+25.2% | -3.13+49.1% | -6.14-15.4% | -5.32+35.6% | -8.27-6.8% | -7.74-34.3% | -5.76 |
| KEY METRICS | ||||||||
| OPM % | 11.84%+24.58pp | -12.74%+77.43pp | -90.17%-23.17pp | -67.00%-28.92pp | -38.08%+50.56pp | -88.64%+9.59pp | -98.23%-28.34pp | -69.89% |
| NPM % | -34.80%-8.25pp | -26.55%+16.41pp | -42.96%+57.04pp | -100.00%-3.06pp | -96.94%+3.06pp | -100.00%-33.96pp | -66.04%-21.52pp | -44.52% |
| EPS | 1.15+5.5% | 1.09+175.2% | -1.45-150.9% | 2.85+15.4% | 2.47-35.5% | 3.83+206.7% | -3.59-34.5% | -2.67 |
Corporate Events
Board MeetingKREBSBIO
202629Sep
Board Meeting
The 34th Annual General Meeting ('AGM') of the Company will …
BSE Filing ↗ Board MeetingKREBSBIO
20266Aug
Board Meeting
The meeting of the Board of Directors will be held to consid…
BSE Filing ↗ Board MeetingKREBSBIO
202411Nov
Board Meeting
Consider and approve Intimation, consider and adopt the Unau…
BSE Filing ↗ Board MeetingKREBSBIO
202421May
Board Meeting
Consider and approve Audited Financial Results
BSE Filing ↗ Board MeetingKREBSBIO
202412Feb
Board Meeting
Consider and approve Unaudited Financial Results of the 3rd …
BSE Filing ↗ Board MeetingKREBSBIO
20238Nov
Board Meeting
Consider and approve un-audited financial results for the qu…
BSE Filing ↗